Skip to main content

Leukemia, lymphoma, and myeloma.

265 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Leukemia, lymphoma, and myeloma265 studies

Relapsed/Refractory B-Cell LymphomaPhase 1/2NCT03223610Papers

ViPOR Combination

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

National Cancer Institute (NCI)Open the brief

B-Non Hodgkin LymphomaPhase 1/2NCT05442515Papers

CD19/CD22-CAR-transduced T cells

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

National Cancer Institute (NCI)Open the brief

Clinical trials: Phase 1 and Phase 2, explained